leila safadel; Farhad Jomehry; Suzan emamipur; omid , Rezaei
Abstract
Objective: Irritable bowel syndrome is a chronic psychosomatic disease. Stressful events play a critical role in thisdisease, and lifestyle modification is one of the treatment priorities for these patients. The present study aimed to examinethe role of health-enhancing lifestyles among stressful life ...
Read More
Objective: Irritable bowel syndrome is a chronic psychosomatic disease. Stressful events play a critical role in thisdisease, and lifestyle modification is one of the treatment priorities for these patients. The present study aimed to examinethe role of health-enhancing lifestyles among stressful life events and salutogenic health indicators in these patients.Method: Data analysis was done by structural equation modeling. The statistical population included all patients withirritable bowel syndrome referred to Imam Sajjad Hospital in Tehran in 2019 and 2020. The statistical sample was 229patients selected through Purposive sampling and diagnosed by a psychiatrist based on ROME-IV criteria. Researchtools included the Bringsen Salutogenic Health Indicators Scale, Sarason Life Events Inventory, and Walker HealthPromoting Lifestyle Profile-II. Data analysis was done by SPSS-20 and LISREL-8 software. Ethical considerationsbased on confidentiality, respect for the rights of individuals, human dignity, and avoiding harming the participants anddistorting information were observed. Also Participants had full authority to withdraw from the study at any timeResults: The relationship between lifestyle (t=2.723, ß=0.17) and stressful events (t=-2.31, ß=-0.42) with salutogenichealth indicators was significant. The mediating role of lifestyle between life events and salutogenic health indicators wasmeaningful at P<005 and a standard coefficient (0.0-13.11).Conclusion: It seems that lifestyle and control over stressful events affect the health indicators of patients with irritablebowel syndrome. Therefore, it is suggested to provide appropriate training programs to control and manage stressfulevents and provide strategies to modify lifestyle to improve health.
atefeh pourkaveh; zabih Pirani; Mehdi Pourasghar; Anahita Sadeghi; Hossein poustchi
Abstract
Objective: Irritable bowel syndrome is a chronic and debilitating digestive disorder that is more common in people withpsychological disorders than in the general population. This study is aimed at the effectiveness of cognitive-behavioraltherapy in the mitigating of chronic pain and cognitive-emotional ...
Read More
Objective: Irritable bowel syndrome is a chronic and debilitating digestive disorder that is more common in people withpsychological disorders than in the general population. This study is aimed at the effectiveness of cognitive-behavioraltherapy in the mitigating of chronic pain and cognitive-emotional regulation in patients with Irritable bowel syndrome.
Method: This study investigates the efficacy of cognitive-behavioral therapy on chronic pains and cognitive emotion regulation in patients with IBS. The research method is quasi-experimental with a pretest-posttest and control group and a six-month followup. All patients with IBS who had presented to the Shariati Hospital of Tehran and Masoud Gastroenterology and Liver Clinic from autumn 2019 to winter 2020 comprised the statistical population. The sample size was 48 people selected by convenience sampling, then divided into an experimental group and a control group using a block randomization procedure (with each group containing 24). Chronic Pain Grade Scale and Cognitive Emotion Regulation Questionnaire were the research tools provided to the two groups. However, the control group remained on the waiting list and received no interventions. The cognitive-behavioral therapy intervention was performed for the experimental group for eight 90-minute sessions. Descriptive statistics and Repeated Measures analyzed research data.
Results: Findings indicated that cognitive-behavioral therapy reduced chronic pain and increased cognitive regulation (p0.01>). This efficacy remained stable until a six-month follow-up (p0.05>).
Conclusion: This finding can also be associated with reducing and improving cognitive emotion regulation within psychological interventions planning vision among patients with IBS, and thus have clinical usages.
